Hemostasis, LLC vs. Nextbiomedical Co., LTD. – Trademark Cancellation TTAB Proceeding 92077653

This Cancellation was filed at the USPTO Trademark Trial and Appeal Board (TTAB) on July 22, 2021 and assigned serial number 92077653 by the TTAB.

Plaintiff:
Hemostasis, LLC represented by THOMAS A. O’ROURKE of BODNER & O’ROURKE, LLP.
Trademark Information: NEXFOAM – US Trademark Serial Number 77560088
View Trademark Status at USPTO
View Trademark Documents at USPTO

Defendant:
Nextbiomedical Co., LTD. represented by JOEL R. SAMUELS of HARNESS, DICKEY & PIERCE, P.L.C..
Trademark Information: NEXSPHERE – US Trademark Serial Number 79284131
View Trademark Status at USPTO
View Trademark Documents at USPTO

Prosecution History:
July 22, 2021 – FILED AND FEE
July 22, 2021 – NOTICE AND TRIAL DATES SENT; ANSWER DUE:
July 22, 2021 – INSTITUTED
August 27, 2021 – ANSWER
December 29, 2021 – P MOT TO AMEND PLEADING/AMENDED PLEADING
January 14, 2022 – PARTIES ALLOWED FIVE DAYS TO RESPOND
January 19, 2022 – D RESP TO BD ORDER/INQUIRY
February 24, 2022 – TRIAL DATES RESET
March 24, 2022 – ANSWER
June 17, 2022 – P MOT FOR EXT W/ CONSENT
June 22, 2022 – EXTENSION OF TIME GRANTED
June 27, 2022 – D CHANGE OF CORRESP ADDRESS
November 18, 2022 – P NOTICE OF RELIANCE
November 22, 2022 – P TESTIMONY
November 22, 2022 – CONFIDENTIAL – PL’S TESTIMONY DECL KESSL
December 02, 2022 – BULKY EXHIBITS CD ROM
January 23, 2023 – D TESTIMONY
January 23, 2023 – D NOTICE OF RELIANCE
January 24, 2023 – D NOTICE OF RELIANCE
January 24, 2023 – CONFIDENTIAL – DEF EXH 53
January 24, 2023 – D CERT OF SERVICE FOR ENTRIES 17 AND 20
January 24, 2023 – DEF CORRECTED CERT OF SERVICE RE ENTRIES17 AND 20
January 27, 2023 – D CD ROM BULKY EXHIBITS
March 07, 2023 – P TESTIMONY
View this TTAB Proceeding at USPTO

About Select IP
Select IP Law Corporation monitors TTAB proceedings that have been instituted. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.

Leave a Reply

Your email address will not be published. Required fields are marked *